Laser Therapy in Basal Cell Carcinoma: Current Evidence, Literature Gaps and Future Perspectives
Bioengineering · 20.02.2026 · 13 (2) · 244
DOI: 10.3390/bioengineering13020244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 20.02.2026. Verfasst von Alessandro Clementi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Sapienza University of Rome, 00185 Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Basal cell carcinoma (BCC) is the most frequent skin cancer, and surgery remains the treatment of choice, particularly in high-risk subtypes and sites. However, in low-risk cases and in patients where cosmetic outcome is a priority, alternative strategies, including laser therapy, have been proposed. Different laser sources offer potential advantages in terms of minimal invasiveness, healing time, and cosmetic outcome, but their clinical role remains a matter of debate. This narrative review critically analyses the available evidence on the use of lasers in the treatment of basal cell carcinoma, with a focus on ablative lasers, vascular lasers, and laser-assisted photodynamic therapy. Mechanisms of action, main clinical results, limitations, and the emerging contribution of non-invasive imaging for case selection and response monitoring are discussed. Ablative lasers, in particular CO2, show favourable results in superficial low-risk BCC, while clearance reliability decreases with increasing tumour depth. Vascular lasers may offer short-term control in selected lesions but with limited long-term data. Laser-assisted PDT represents a promising strategy to extend the indication of PDT to selected nodular forms. Overall, the literature is limited by methodological heterogeneity, incomplete stratification, and short follow-ups. Well-designed comparative studies, standardised protocols, and objective controls will be essential to define the real clinical space of laser therapy in basal cell carcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences, Sapienza University of Rome, 00185 Rome, Italy.
- Department of Plastic, Reconstructive and Cosmetic Surgery, Campus Bio-Medico University Hospital, 00128 Rome, Italy.
- Department of Dermatology, University of Modena and Reggio Emilia, 41124 Modena, Italy.
ORCID-Profile: Alessandro Clementi, Luca Guarino, Luca Gargano, Martina Tolone, Elena Zappia, Marco Gratteri, Caterina Longo, Steven Paul Nisticò
Zitieren
APA
Clementi, A., Cannarozzo, G., Guarino, L., Gargano, L., Tolone, M., Zappia, E., Gratteri, M., Dattola, A., Longo, C., Pellacani, G., & Nisticò, S. P. (2026). Laser Therapy in Basal Cell Carcinoma: Current Evidence, Literature Gaps and Future Perspectives. Bioengineering, 13(2), 244. https://doi.org/10.3390/bioengineering13020244
Vancouver
Clementi A, Cannarozzo G, Guarino L, Gargano L, Tolone M, Zappia E, et al. Laser Therapy in Basal Cell Carcinoma: Current Evidence, Literature Gaps and Future Perspectives. Bioengineering. 2026;13(2):244. doi:10.3390/bioengineering13020244
BibTeX
@article{Clementi2026,
author = {Clementi, Alessandro and Cannarozzo, Giovanni and Guarino, Luca and Gargano, Luca and Tolone, Martina and Zappia, Elena and Gratteri, Marco and Dattola, Annunziata and Longo, Caterina and Pellacani, Giovanni and Nisticò, Steven Paul},
title = {Laser Therapy in Basal Cell Carcinoma: Current Evidence, Literature Gaps and Future Perspectives},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {2},
pages = {244},
doi = {10.3390/bioengineering13020244}
}
EUVIMED